Stock Screener App

Gratuito -

Drug Manufacturers - Specialty & Generic

25.47

0.04% +0.010

Dopo l'orario di chiusura: 25.45 -0.02 -0.08%

Deciphera Pharmaceuticals Inc (DCPH)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Deciphera Pharmaceuticals Inc Borsa (DCPH) Ultime notizie

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RBAZ Bancorp, Inc. (OTCPK – RBAZ), Squarespace, Inc. (NYSE – SQSP), PlayAGS, Incorporated (NYSE – AGS), Deciphera Pharmaceuticals, Inc. (Nasdaq – D - ForexTV.com

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RBAZ Bancorp, Inc ... - GlobeNewswire

(DCPH) On The My Stocks Page - Stock Traders Daily

Stock Traders Daily

Russell Investments Group Ltd. Acquires 7326 Shares of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) - Defense World

Panagora Asset Management Inc. Has $3.80 Million Position in Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) - MarketBeat

Can Deciphera Pharmaceuticals, Inc. (DCPH) Climb 79% to Reach the Level Wall Street Analysts Expect? - Yahoo Movies Canada

Yahoo Movies Canada

Deciphera to be acquired by Japan's Ono in all-cash deal valued at $2.4 billion - MSN

New York State Common Retirement Fund Has $383000 Stock Position in Deciphera Pharmaceuticals, Inc. (NASDAQ ... - Defense World

Can Deciphera Pharmaceuticals, Inc. (DCPH) Climb 79% to Reach the Level Wall Street Analysts Expect? - Yahoo Movies Canada

Yahoo Movies Canada

Deciphera Pharmaceuticals (NASDAQ:DCPH) Sees Unusually-High Trading Volume - MarketBeat

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Squarespace, Inc ... - Morningstar

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Squarespace, Inc ... - GlobeNewswire

Is the Options Market Predicting a Spike in Deciphera (DCPH) Stock? - Yahoo Lifestyle UK

Yahoo Lifestyle UK

DCPH Stock Earnings: Deciphera Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024 - MSN

Deciphera Pharmaceuticals, Inc. (DCPH) Down 15% Since Last Earnings Report: Can It Rebound? - Yahoo Canada Shine On

Yahoo Canada Shine On

Deciphera Pharmaceuticals (NASDAQ:DCPH) Reaches New 12-Month High at $25.55 - Defense World

Deciphera Pharmaceuticals (DCPH) Stock Forecast and Price Target 2024 - MarketBeat

Fisher Asset Management LLC Takes $1.01 Million Position in Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) - MarketBeat

Deciphera Pharmaceuticals (NASDAQ:DCPH) Sets New 1-Year High at $25.55 - MarketBeat

Analysts Estimate Deciphera Pharmaceuticals, Inc. (DCPH) to Report a Decline in Earnings: What to Look Out for - Yahoo News UK

Here's What Key Metrics Tell Us About Deciphera Pharmaceuticals (DCPH) Q1 Earnings - Yahoo Finance

Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Canada Finance

Yahoo Canada Finance

Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q1 Loss, Misses Revenue Estimates - Zacks Investment Research

Zacks Investment Research

How the (DCPH) price action is used to our Advantage - Stock Traders Daily

Stock Traders Daily

Deciphera Pharmaceuticals (NASDAQ:DCPH) Sets New 1-Year High at $25.55 - MarketBeat

AnaptysBio, Inc. (ANAB) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: PlayAGS ... - GlobeNewswire

Analysts Estimate Deciphera Pharmaceuticals, Inc. (DCPH) to Report a Decline in Earnings: What to Look Out for - Yahoo News UK

Deciphera Pharmaceuticals (DCPH) – Investment Analysts' Weekly Ratings Changes - Defense World

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: PlayAGS ... - GlobeNewswire

Deciphera Pharmaceuticals (NASDAQ:DCPH) shareholders have endured a 66% loss from investing in the stock three ... - Yahoo Lifestyle UK

Yahoo Lifestyle UK

Deciphera Pharmaceuticals, Inc. to Post Q1 2025 Earnings of ($0.57) Per Share, Zacks Research Forecasts (NASDAQ ... - MarketBeat

Zacks Research Analysts Cut Earnings Estimates for Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) - Defense World

Wall Street Breakfast: The Week Ahead

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DCPH, HTLF, DPSI, UNIT - ForexTV.com

The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine

Zacks Investment Research

The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine - Yahoo Finance

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Sees Significant Decline in Short Interest - Defense World

Deciphera Pharmaceuticals (NASDAQ:DCPH) Stock Rating Reaffirmed by JMP Securities - Defense World

Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More

Zacks Investment Research

Barclays Upgrades Deciphera Pharmaceuticals (NASDAQ:DCPH) to “Equal Weight” - Defense World

Deciphera acquisition by ONO Pharmaceutical at $2.4 billion - Investing.com India

Investing.com India

DECIPHERA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates ... - Business Wire

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Short Interest Down 5.1% in April - MarketBeat

Deciphera Pharmaceuticals Inc (DCPH) Performance and Fundamentals Dashboard tells a completely different story ... - SETE News

Deciphera Pharmaceuticals' (DCPH) Neutral Rating Reiterated at Guggenheim - MarketBeat

Deep Dive Into Deciphera Pharmaceuticals Stock: Analyst Perspectives (5 Ratings)

ONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals - PR Newswire

Deciphera Pharmaceuticals' (DCPH) Neutral Rating Reiterated at Guggenheim - MarketBeat

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HashiCorp Inc ... - GlobeNewswire

$65.32

0.49%

$17.00

1.11%

$55.00

0.67%

$68.71

0.66%

$11.07

0.82%

$141.65

0.45%

Apri su Yahoo | Apri su Google | Aperto in Finviz